1281 related articles for article (PubMed ID: 29188475)
1. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
3. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
5. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
[TBL] [Abstract][Full Text] [Related]
6. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
7. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
10. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management.
Frantz R; Huang S; Are A; Motaparthi K
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577817
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study.
Kridin K; Brüggen MC; Chua SL; Bygum A; Walsh S; Nägeli MC; Kucinskiene V; French L; Tétart F; Didona B; Milpied B; Ranki A; Salavastru C; Brezinová E; Divani-Patel S; Lorentzen T; Nagel JL; Valiukeviciene S; Karpaviciute V; Tiplica GS; Oppel E; Oschmann A; de Prost N; Vorobyev A; Ingen-Housz-Oro S
JAMA Dermatol; 2021 Oct; 157(10):1182-1190. PubMed ID: 34431984
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A; Abe R
F1000Res; 2020; 9():. PubMed ID: 32595945
[TBL] [Abstract][Full Text] [Related]
13. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine.
Chen CB; Wang CW; Chung WH
Methods Mol Biol; 2022; 2486():37-54. PubMed ID: 35437717
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine in SJS/TEN management: a brief review.
Shokeen D
Cutis; 2016 Mar; 97(3):E17-8. PubMed ID: 27023091
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Fritsch PO; Sidoroff A
Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
[TBL] [Abstract][Full Text] [Related]
17. [Acute life-threatening drug reactions of the skin].
Mockenhaupt M
Hautarzt; 2018 May; 69(5):364-375. PubMed ID: 29721625
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Gleghorn KL; Voigt C; Kelly B
Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation.
Schmidt V; Lalevée S; Traidl S; Ameri M; Ziadlou R; Ingen-Housz-Oro S; Barau C; de Prost N; Nägeli M; Mitamura Y; Meier-Schiesser B; Navarini AA; French LE; Contassot E; Brüggen MC
Allergy; 2023 May; 78(5):1280-1291. PubMed ID: 36463488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
